Together with the finding that brain-specific deletion of Ndufs4 replicates pathological features of LS [27], these studies consolidate the idea that gene replacement strategies must target the central nervous system in order to provide a robust therapeutic effect. The gene discussed is NDUFS4; the disease is Leigh syndrome.